Previous Article | Next Article ![]()
Journal of Bacteriology, February 2009, p. 1162-1168, Vol. 191, No. 4
0021-9193/09/$08.00+0 doi:10.1128/JB.01137-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Microbiology, School of Natural Sciences,1 Nanoscale Biophotonics Laboratory, School of Chemistry,2 National Centre for Biomedical Engineering Science, National University of Ireland, Galway, Galway, Ireland,3 Department of Chemical and Environmental Sciences and Materials and Surface Science Institute, University of Limerick, National Technology Park, Limerick, Ireland4
Received 13 August 2008/ Accepted 25 November 2008
|
|
|---|
|
|
|---|
TF is highly abundant in E. coli (up to 40 µM), with most TF molecules existing in an equilibrium between its monomeric and dimeric states in the cytosol (28). The high cytosolic concentration of TF has recently been linked to a distinct functional role of the chaperone in maintaining newly translated polypeptides in a folding-competent state in the E. coli cytoplasm (35). A distinct antichaperone activity has also been described for TF, however, whereby substoichiometric concentrations of TF lead to increased polypeptide aggregation, whereas high TF/polypeptide ratios can also delay folding as the chaperone maintains polypeptides in a non-native state without promoting their complete refolding (9).
E. coli TF (TFEc) is composed of an N-terminal ribosome-binding tail (domain I), an internal domain with peptidyl-prolyl cis/trans isomerase (PPIase) activity (domain II), and a C-terminal domain III that is involved in its chaperone activity (26). The importance of the PPIase domain remains unclear as TF binds non-native nascent polypeptides lacking proline residues (29), while its PPIase activity is also not required for its chaperoning function (15).
Cold-adapted microorganisms, such as psychrophiles and psychrotrophs, are capable of growth at temperatures as low as 0°C. Few molecular chaperones from such bacteria have been investigated in detail, and although TF homologues have been identified in the genomes of pychrophiles such as Pseudoalteromonas haloplanktis, Psychrobacter arcticus, or Shewanella frigidimarina, neither their biochemistry nor their importance in cold adaptation has been characterized to the same degree as for GroEL (36). Here, therefore, we present the first detailed investigation of a cold-adapted TF homologue, from Psychrobacter frigidicola (TFPf), and reveal its unexpected behavior: TFPf displays no dimerization, and, importantly, does not exhibit the in vitro chaperonelike holding activity characteristic of TF.
|
|
|---|
tig (6) were used for protein translocation studies. The pIG6scFv2H12 vector was used for expression of the 2H12 scFv antibody fragment (7). pACYC184 and pBADHisB were obtained from NEB Biolabs and Invitrogen, respectively. Cloning of P. frigidicola tig gene. DNA manipulations were carried out according to the method of Sambrook and Russell (30a). A 3' partial sequence of the tig gene was initially amplified from P. frigidicola genomic DNA by PCR using degenerate primers. The 5' region was then amplified with the primers TFS1 (CTTGGCTACGCGCAGCATTTTTGATTTCG) and TFS2 (GCCGCTTTACCAGCCAATTCTTCAGCTTGG) using an LA Taq PCR in vitro cloning kit (Takara Corp.). The complete arabinose promoter cassette from pBADHisB was amplified and cloned into HindIII-digested pACYC184 to yield the expression vector p15ara. Finally, complete tig genes from P. frigidicola (tigPF) and E. coli (tigEc) were amplified by PCR with or without a C-terminal His6 tag and 5'-NdeI and 3'-PstI flanking restriction sites and cloned using these sites into p15ara to yield p15aratighisPF and p15aratighisEC vectors. The tigPf and tigEc genes were subcloned without His6 tags as BamHI/PstI and BamHI/XhoI fragments, respectively, into pBADHisB.
Expression and purification of TFs from E. coli and P. frigidicola. TFPf and TFEc were expressed from p15aratighisPF and p15aratighisEC, respectively, in E. coli BL21(DE3). Expression was induced at 25°C in Luria-Bertani medium by the addition of 1 mg of arabinose/ml. The cells were harvested, and proteins were extracted in buffer A (100 mM NaCl, 10 mM imidazole, 2 mM β-mercaptoethanol, 20 mM Tris-HCl [pH 8.0]) with the addition of 5% CelLytic reagent (Sigma-Aldrich), 0.3 kU of rLysozyme (Invitrogen)/ml, and 50 µg of DNase I (Sigma-Aldrich)/ml. After centrifugation at 14,000 rpm for 30 min at 4°C, the samples were loaded onto a Ni2+-NTA HiTrap cartridge (GE Healthcare), followed by stepwise washing of the resin with buffer A containing NaCl from 100 to 500 mM. The resin was then washed with buffer A containing imidazole from 20 to 250 mM, and fractions containing eluted TF were pooled, dialyzed against 20 mM Tris-HCl (pH 8.0) and 1 mM dithiothreitol at 4°C overnight, concentrated, and snap-frozen in liquid nitrogen. Fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting (16).
GAPDH refolding assay. Refolding of denatured GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was performed based on Huang et al. (10). Denatured enzyme was diluted 50-fold in GAPDH buffer (0.1 M potassium phosphate [pH 7.5], 1 mM EDTA, 5 mM dithiothreitol) containing 0.625, 1.25, 2.5, 3.75, 5, 7.5, 10, or 20 µM TF. The reaction was maintained at 4°C for 30 min, followed by 180 min at 25°C or 15°C. The GAPDH activity was measured by mixing 1-µl reaction aliquots with 99 µl of GAPDH buffer in the presence of 700 µM β-NAD (Sigma-Aldrich) and 700 µM D-L-glyceraldehyde-3-phosphate (Sigma-Aldrich). This was followed by measurement of the synthesized NADH at 340 nm (Tecan microplate spectrophotometer; Genios). The data were fitted to a single exponential equation (Prism program; GraphPad Software), and the relative activity recovered was calculated by dividing the rate constant for refolded GAPDH by the rate constant determined with nondenatured enzyme.
RCM-RNase T1 refolding assay. RNase T1 from Aspergillus oryzae (Sigma-Aldrich) was denatured, reduced, and carboxymethylated using dithiothreitol as the reducing agent, according to the published protocol (27). Refolding was induced by dilution of reduced and carboxymethylated RNase T1 (RCM-RNase T1) to a final concentration of 0.5 µM in 1.6 M NaCl-0.1 M Tris-HCl (pH 8.0) in a spectrofluorometer (Cary Eclipse; Varian). TFPf or TFEc was included in the reaction mixture at 0.1 or 0.2 µM. The data were fitted to a single-exponential equation (Prism program).
Glutaraldehyde cross-linking. TFPf or TFEc (5 µg) was incubated at concentrations of 0.5, 2.5, 10, 20, or 30 µM for assays at 25°C and at 0.15, 0.625, 2.5, 10, or 20 µM for assays at 15°C in 20 mM HEPES (pH 7.5)-100 mM NaCl-1 mM EDTA for 25 min. Cross-linking was initiated by the addition of 0.1% glutaraldehyde, and the reaction was quenched after 15 min by incubation in 100 mM Tris-HCl (pH 8) for 10 min at the relevant assay temperature. Samples were precipitated for 10 min on ice using 10% trichloroacetic acid and centrifuged at 14,000 rpm and 4°C for 30 min. Pellets were solubilized in 8 M urea in phosphate-buffered saline (PBS), and samples were analyzed by SDS-PAGE (10% gel) and Coomassie brilliant blue staining.
Fluorescence anisotropy.
Both TFPf and TFEc were labeled by using the Alexa Fluor 532 monoclonal antibody kit (Molecular Probes) according to the manufacturers' protocol. The procedure was optimized to achieve a labeling ratio of approximately one fluorophore per protein. The concentration of protein (M) was calculated by using UV-visible absorption spectroscopy and the following formula: M = (A280 – (A530 x 0.09))/
280, where A280 is the absorbance at 280 nm and A530 is the absorbance at 530 nm, with
280 TFPf = 10,240 cm–1 M–1 and
280 TFEc = 15,930 cm–1 M–1. Labeling ratios (LR) of 1.1 for TFPf and 1.3 for TFEc were calculated by using the following formula: LR = A530/(81,000 x M).
Alexa Fluor 532-labeled TFPf or TFEc (50 nM) was titrated with increasing concentrations of the corresponding unlabeled TF, followed by detection of TF homodimerization by observation of the change in fluorescence anisotropy (r). Fluorescence was measured in a Cary Eclipse spectrofluorometer (Varian) equipped with a variable temperature, Peltier-controlled cell holder (TLC-50F Quantum Northwest) and manual excitation and emission polarizers. The excitation wavelength was 532 nm, and the emission wavelength was 554 nm. The excitation and emission slits were set at 5 and 20 nm, respectively. Anisotropy was measured by using an L-format detection configuration. All titration measurements were performed in 20 mM Tris-HCl-150 mM NaCl-1 mM EDTA buffer (pH 7.5), and samples were incubated at 25°C. Experiments were performed in triplicate, and data were fitted (Origin Software, version 7.5; OriginLab) by using the following equation:
![]() |
TF-assisted cell-free protein synthesis. The gene encoding the 2H12 anti-domoic acid scFv antibody fragment was amplified from pIG6scFv2H12 (7), and a T7 promoter was added by overlap PCR. A recombinant M2 FLAG tag was also added at the C terminus of the encoded scFv to detect the synthesized protein. Cell-free translation of the scFv was carried out using 2 pmol/µl of linear template in the PURE System (Post Genome Institute Co., Ltd.), according to the manufacturer's instructions. Where indicated, TFPf or TFEc was added at 2.5, 5, 10, or 20 µM. After incubation for 1 h at 37°C, an equal volume of water was added, and samples were centrifuged at 14,000 rpm and 4°C for 20 min. Pellets were solubilized in 8 M urea in PBS, and soluble and insoluble fractions were analyzed by SDS-PAGE and Western blotting with an anti-M2 FLAG antibody. The binding of scFv molecules was tested by enzyme-linked immunosorbent assay (ELISA) according to published procedures (7). Briefly, wells of a 96-well microtiter plate were coated with 10 µg of domoic acid (Calbiochem, United Kingdom)/ml conjugated to ovalbumin, followed by blocking with 5% milk powder in PBS. Detection of bound scFv was carried out with an anti-M2 FLAG antibody, followed by the addition of an anti-mouse peroxidase-conjugated antibody and TMB substrate (Sigma-Aldrich).
scFv2H12 export monitoring.
E. coli BL21(DE3) cells containing pIG6scFv2H12 and either p15aratigPF or p15aratigEC plasmids were grown in LB medium containing 1 mg of arabinose/ml at 37°C. Alternatively, E. coli W3110 or E. coli W3110
tig cells containing pIG6scFv2H12 and pBADHisB, pBADtigPF, or pBADtigEC constructs were grown at 37°C in LB medium containing 0.05 to 0.125 mg of arabinose/ml. When the optical density at 600 nm reached
0.5, scFv expression was induced by the addition of 1 mM IPTG (isopropyl-β-D-thiogalactopyranoside), followed by growth at 25°C for 3 h. The cells were harvested, and protein was extracted with 5% CelLytic reagent, 0.3 kU of rLysozyme/ml, and 50 µg of DNase I/ml in PBS. Insoluble protein fractions were pelleted by centrifugation at 14,000 rpm and 4°C for 20 min and solubilized in 8 M urea in PBS. Soluble and insoluble fractions were analyzed by SDS-PAGE and Western blotting with an anti-His6 tag peroxidase-conjugated antibody.
|
|
|---|
![]() View larger version (53K): [in a new window] |
FIG. 1. Sequence alignment of trigger factors from P. frigidicola and E. coli. The predicted amino acid sequences of E. coli and P. frigidicola TFs were aligned using CLUSTAL W (34). Invariant residues are indicated on a black background, and similar residues are indicated on a gray background. Predicted secondary structures, determined with PORTER (30), are shown above the TFPf and below the TFEc sequences: -helices are drawn as cylinders, β-strands are drawn as arrows, and other elements are drawn as solid lines. The conserved ribosome-binding motif is boxed in dashed lines, and residues conserved in the PPIase catalytic site are indicated by diamonds.
|
![]() View larger version (10K): [in a new window] |
FIG. 2. PPIase activity of P. frigidicola and E. coli TFs. PPIase activity of TFs against the RCM-RNase T1 model substrate. RCM-RNase T1 refolding was monitored by an increase in intrinsic tryptophan fluorescence at 320 nm after excitation at 268 nm. Symbols: , TFPf; , TFEc; x, buffer.
|
![]() View larger version (10K): [in a new window] |
FIG. 3. Effect of TF concentration on reactivation of GAPDH at 25°C and 15°C. Refolding of denatured GAPDH was monitored by measuring its enzymatic activity 3 h after 50-fold dilution (final concentration 2.5 µM) in the presence of increasing concentrations of TFPf (), TFEc ( ), or BSA (x) at 25°C (A) or at 15°C (B).
|
Since the suppression of GAPDH reactivation by TFEc has been attributed to the ability of TFEc to dimerize and complex with partially folded GAPDH, we compared the dimerization ability of both TFs in order to determine the basis for the difference between the polypeptide-holding properties of the two chaperones.
TFPf does not form dimers in vitro. Previously published studies indicate that TFEc exists in a monomer-dimer equilibrium in solution (28). In order to investigate TFPf dimerization, therefore, we initially utilized a glutaraldehyde cross-linking approach to determine the quaternary structure of the purified chaperone at different concentrations.
As expected, TFEc exhibited extensive, concentration-dependent dimerization, leading to the appearance of a dominant product with abnormal migration that corresponds to
175 kDa (Fig. 4A, star). Higher-molecular-weight products visible in the gel at higher TFEc concentrations are most likely higher oligomeric or aggregated species. Strikingly, TFPf did not undergo a monomer-to-dimer conversion, even at concentrations as high as 30 µM. While this observation is important in demonstrating that dimerization of TF is not a prerequisite for its chaperone function reported in Fig. 3, it also supports the hypothesis that dimer formation may be important in its polypeptide holding ability. In order to investigate dimerization under conditions more physiologically relevant to TFPf, cross-linking was repeated at 15°C, at which temperature both TFs presented behavior similar to that observed at 25°C (Fig. 4B).
![]() View larger version (77K): [in a new window] |
FIG. 4. Analysis of quaternary structures of TFs at 25°C and 15°C by cross-linking. Increasing concentrations (indicated by triangles above the lanes) of TFPf and TFEc were cross-linked using 0.1% glutaraldehyde, precipitated using trichloroacetic acid, and separated by SDS-10% PAGE. (A) Cross-linking at 25°C, with TF concentrations of 0.5, 2.5, 10, 20; and 30 µM; (B) cross-linking at 15°C, with TF concentrations of 0.15, 0.625, 2.5, 10, and 20 µM. Equal amounts of protein were loaded in each lane. The first lane of each TF gradient was not treated with glutaraldehyde. Cross-linked dimers are indicated by stars.
|
Titration of fluorescently labeled TFs with the corresponding unlabeled TF allowed the resultant changes in anisotropy to be plotted against the concentration of unlabeled TF, with data fitted to a model specific for dimerization, according to the equation for calculating robs provided above. Equilibration of 50 nM labeled TFEc with the unlabeled chaperone at concentrations of up to 100 µM yielded a significant increase in anisotropy (Fig. 5), indicating multimerization of TFEc with a dimer-monomer dissociation constant of 2.8 ± 0.3 µM. This measurement is consistent with the range of Kd values previously determined for TFEc by using high-pressure liquid chromatography (1 µM) (28) and analytical ultracentrifugation (23, 28), which validated the approach prior to characterization of the P. frigidicola chaperone.
![]() View larger version (9K): [in a new window] |
FIG. 5. Analysis of quaternary structure of TFs at 25°C by fluorescence anisotropy. Alexa Fluor 532-TF (50 nM) was titrated against increasing concentrations of unlabeled TF. The change in anisotropy is plotted against the unlabeled protein concentration, as indicated. Symbols: , TFPf; , TFEc.
|
In order to further delineate functional differences between the E. coli and P. frigidicola TFs that may arise from their different quaternary structures, we investigated the ability of TFPf to complement a
tig mutation in the E. coli GP179 (MC4100
tig
dnaKJ) host strain (6). Despite successful complementation by TFEc, however, it was not possible to assess complementation by TFPf due to its low-level expression under the same conditions in the E. coli host (data not shown).
TFPf exhibits reduced retardation of protein export in E. coli. Previous studies indicate that TFEc, upon binding nascent polypeptides under physiological conditions, can impede their export from the cytoplasm. Since this effect is inversely proportional to the concentration of TF in the cytoplasm (19), it raises the possibility that it might be mediated by the dimeric form of TF (20). Previous work by our own group also demonstrated that periplasmic export of a recombinant scFv antibody fragment, with an OmpA leader peptide, was severely impaired upon coproduction of TFEc (8). In order to further investigate the potential significance of the lack of dimerization of TFPf observed in vitro, therefore, we used the same scFv expression model to examine the effect of TFPf on retarding polypeptide translocation of the cytoplasmic membrane in E. coli.
Upon coproduction of TFEc, the 2H12 scFv occurred almost exclusively in its unprocessed form in E. coli BL21, i.e., with the OmpA leader peptide still attached at its N terminus (Fig. 6A). This indicates that translocation of the recombinant polypeptide across the cytoplasmic membrane is almost completely blocked by elevated intracellular concentrations of TFEc. Coproduction of TFPf at a similar level and under the same conditions had no such effect on scFv secretion, however, since only the processed (and, therefore, translocated) form of the scFv was detectable in cellular preparations (Fig. 6A). In order to investigate whether this lack of retardation could be due to competition for substrate between TFPf and endogenous TFEc in the cell, the export analysis was repeated in parallel in E. coli W3110 and E. coli W3110
tig strains. While an unprocessed scFv product could be detected in TFPf-expressing cultures in this analysis, albeit at a dramatically lower concentration than with the E. coli chaperone, no difference in protein export was observed between the parental and
tig strains (Fig. 6B). Therefore, the lack of retardation observed with TFPf is likely to be due to its inability to form stable complexes with newly translated polypeptides during folding, unlike TFEc which remains stably bound to nascent polypeptide chains for extended periods (19) and so impedes their secretion.
![]() View larger version (20K): [in a new window] |
FIG. 6. Effect of TFs on the periplasmic export of 2H12 scFv in E. coli. (A) 2H12 scFv was expressed in E. coli BL21(DE3) cells, with TFPf and TFEc coexpressed from p15aratigPF and p15aratigEC, respectively. Soluble (upper) and insoluble (lower) fractions were analyzed by Western blotting with an anti-His6 tag antibody. (B) pBADHisB + tigPf and + tigEc represent E. coli W3110 or E. coli W3110 tig cells expressing 2H12 scFv in the presence of pBADHisB control, pBADtigPF, and pBADtigEC plasmids, respectively. Whole-cell extracts were analyzed as described above. Arrows indicate bands of the expected sizes of the processed and unprocessed scFv polypeptides.
|
We added TFEc or TFPf during translation of the scFv to create a coupled translation-folding scheme in vitro. Analysis of the reactions clearly indicated that TFPf does not simply suppress the aggregation of the scFv, as indicated by Western blot analysis, but also assists its correct folding, as judged by ELISA (Fig. 7). This effect was independent of TFPf concentration in the range 2.5 to 20 µM, whereas the addition of up to 20 µM TFEc led to no improvement in either the solubility or the yield of functional scFv. Conversely, the two TFs led to similar increases in the solubility and functionality of the same 2H12 scFv in E. coli cell expression experiments, however, resulting in up to sixfold increases in the volumetric yield of functional scFv (data not shown). This apparent discrepancy between the effects of E. coli TF on scFv folding in cell-free and cell-based environments can be explained by its requirement to transfer many aggregation-sensitive proteins to downstream chaperone systems such as DnaK/J/GrpE or GroES/EL in the cell to ensure their successful folding (11). Of considerably more interest to the present study, however, is the fact that TFPf could assist the folding of the target protein independently of downstream chaperone machineries, providing another indication of the significantly different folding properties of the P. frigidicola and E. coli chaperones.
![]() View larger version (33K): [in a new window] |
FIG. 7. Effect of increasing concentrations of TFs on cell-free protein synthesis. Various concentrations of TFPf and TFEc were added to a cell-free protein synthesis system prior to production of the 2H12 scFv recombinant antibody fragment. Activity of the soluble scFv was monitored by ELISA. Soluble and insoluble fractions were separated by centrifugation and analyzed by Western blotting with an anti-M2 FLAG antibody. The results are representative of two independent experiments.
|
This first characterization of a TF from a psychrophilic species has revealed striking properties of TFPf. In combination with other recent studies in the field (18, 25, 32, 37), it significantly advances our molecular understanding of the functioning of TF. Given in particular that a specific mechanistic role has been proposed for dimeric TFEc in posttranslational protein folding (20), the present results highlight that dimerization may not be a universal feature among bacteria and that the physiological relevance of dimer formation remains to be fully understood.
tig strains and for helpful discussions and A. Schröder for technical assistance. This study was supported by grant CFTD/04/106 from Enterprise Ireland Science and Technology Agency (S.R.). D.M.T. and A.G.R. acknowledge the support of the National Biophotonics Imaging Platform, a PRTLI-IV funded initiative, and Science Foundation Ireland for the fluorescence instrumentation.
Published ahead of print on 5 December 2008. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»